• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Contract Manufacturing: Trials & Tribulations of Today’s Supply Chains

    Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality

    Nutrition and Flavor: Formulating for Modern Product Preferences

    What Do Consumers Know About the Gut Microbiome?

    How Will the European Green Deal Impact Dietary Supplements?
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process

    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market

    Tazo Transitions to Regenerative Organic Agriculture

    Protein Ingredient Formulated for Chronic Kidney Disease Patients

    IADSA Calls for Addressing Discrepancies in Vitamin C Recommendations
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Fact or Myth: Antioxidants Negatively Impact Iron Absorption

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process

    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market

    Tazo Transitions to Regenerative Organic Agriculture

    Protein Ingredient Formulated for Chronic Kidney Disease Patients
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Fact or Myth: Antioxidants Negatively Impact Iron Absorption

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process

    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market

    Tazo Transitions to Regenerative Organic Agriculture

    Protein Ingredient Formulated for Chronic Kidney Disease Patients
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process

    Caffeine-Free Energy Supplement Linked to Alertness, Fatigue Benefits

    Monk Fruit Sweetener May Have Prebiotic Activity, Study Finds

    People with Low-Fiber Diets Benefit the Most from Fiber Supplements, Study Finds

    Gut Microbiome May Be Part of Link Between Red Meat and Heart Disease Risk
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    ESHA Research

    BGG World

    PhytoGaia Inc

    KLK OLEO

    Atlantia Clinical Trials
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    ESHA Research

    BGG World

    PhytoGaia Inc

    KLK OLEO

    Atlantia Clinical Trials
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    FDA Rejection of NDINs for Full Spectrum Hemp Extracts Fails to See Key Differences from Drugs

    Multicomponent hemp extracts with trace levels of THC and other naturally occurring compounds have not been approved in any new drug.

    FDA Rejection of NDINs for Full Spectrum Hemp Extracts Fails to See Key Differences from Drugs
    Related CONTENT
    • Food Processing for Health and Wellness
    • Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality
    • Lynside® Forte B offers full range of B-vitamin benefits with nutritional yeast
    • New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance
    • FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products
    By Todd Harrison, Venable09.09.21
    By now, you may be aware that two pioneering companies, Irwin Naturals and Charlotte’s Web, answered the FDA bell and notified the agency of their intent to market full spectrum hemp extracts (FSHE) with low levels of cannabidiol (CBD). However, while the FDA permitted the filing of the notifications, as required by the law, the agency continued to assert that a product containing CBD is precluded from being marketed as a dietary supplement.

    FDA’s position strains credulity at best. Simply stated, FSHE is not excluded from the definition of a dietary supplement because of the following: 1) FSHE is not the same “article” that has been subject to substantial, publicly disclosed clinical investigations as a drug; and 2) FSHE has been marketed as a food and as a dietary supplement prior to any substantial clinical trials investigating cannabis-derived compounds, including CBD isolates. This column discusses whether FSHE is the same article as Epidiolex and/or Sativex.

    Making Sense of the Arguments
    FDA’s statements that the presence of CBD in FSHE excludes them from dietary ingredient status are without merit. FDA relies heavily on the cultivation and manufacturing process that assures the quality and quantity of CBD as evidence the product is equivalent to Epidiolex and Sativex. FDA arrives at this conclusion based upon the statutory definition of a “dietary supplement” under section 201(ff) of the Food, Drug, and Cosmetic Act (FDCA).

    Specifically, that statutory provision provides in relevant part that “an article” may not be marketed as a dietary supplement, if all of the following are true: 1) it has been authorized for investigation as a new drug; 2) substantial clinical investigations have been instituted on the article and their existence made public; and 3) it was not marketed as a food or dietary supplement prior to being authorized for investigation as a new drug. For purposes of this exclusion, FDA has interpreted “authorized for investigation as a new drug” to mean that an investigational new drug application (IND) has been submitted for the active ingredient or active moiety.  

    The key issue is whether FSHE is “an article” that has either been approved or investigated as a “drug.” I understand FDA’s position to be that all CBD is the same “article,” which would mean that substantial clinical investigations instituted and made public by GW Pharma several years ago preclude the use of CBD in a dietary supplement—absent evidence establishing that CBD was marketed in dietary supplements prior to GW Pharma’s public announcement of the clinical investigations. 

    A careful reading of the statute strongly indicates that FDA’s position is contrary to Congressional intent. Congress intended to strike a balance between maintaining the incentive to develop new drugs while allowing access to dietary supplements that may contain a constituent that is the active moiety in the drug, but would not be expected to have the same  pharmacological effect. This interpretation is consistent with the Tenth Circuit’s decision in Pharmanex v. Shalala—the seminal case interpreting this provision of section 201(ff) (Pharmanex, Inc. v. Shalala, 221 F.3d 1151 (10th Cir. 2000); 2001 U.S. Dist. LEXIS 4598 (D. Utah  Mar. 30, 2001) (district court opinion on remand)).

    The Pharmanex case involved a company that developed a proprietary manufacturing process capable of increasing the levels of lovastatin in red yeast rice above the naturally occurring trace levels. FDA took the position that the particular red yeast rice used in Pharmanex’s Cholestin product was precluded under section 201(ff) from being marketed as a dietary ingredient, because it was not present in the food supply prior to FDA’s approval of lovastatin as a drug.

    In upholding FDA’s interpretation of section 201(ff), the court noted that Cholestin was pharmacologically equivalent to the lowest-dose lovastatin product marketed by Merck.

    In order to fit this paradigm, FDA indicates that a mere 65 mg of CBD is functionally equivalent to Epidiolex, which based on any reasonable calculation requires a minimum of 700 mg of CBD to exert its effect.

    This is certainly not the same as the red yeast rice that was the subject of the Pharmanex case; Cholestin contained the same level of lovastatin as the FDA-approved drug. Indeed, the court’s decision was compelled by the fact that, from a pharmacological viewpoint, Pharmanex’s red yeast rice was indistinguishable from Merck’s lovastatin in identity of active ingredient, strength of active ingredient, and mode of action. This is simply not the case with regard to the FSHE ingredients that were the subject of the recent New Dietary Ingredient Notifications (NDINs).

    Unique Extracts
    Importantly, studies have shown that multi-component cannabis extracts have displayed differentiated dose-response curves when compared to CBD isolates. Cannabis contains hundreds of compounds and various preclinical studies have shown that different cannabinoids  display unique pharmacological and pharmacokinetic profiles.

    Furthermore, studies demonstrating the interplay between cannabinoids and other classes of compounds have established the fact that chemical synergy results in unique pharmacological effects. Pharmaceutical drugs consisting of one or two active cannabinoids, at specific standardized amounts, will have distinct mechanisms of action compared to full-spectrum extracts, and each other. FDA simply ignores this fact and does not even attempt to address it.

    Indeed, pharmaceutical drugs created from cannabis extracts are an example of how small changes in the ratios of the same cannabinoids can have major consequences in terms of  efficacy and pharmacology. For sure, the FSHE in the NDINs had unique chemical profiles when  compared to approved drugs. Moreover, the maximum proposed daily amount of CBD from intake of the FSHE differs from that present in Epidiolex. Having established that chemical profile differences translate to changes in pharmacological action, FDA’s position that any level of CBD excludes the ingredient from being eligible as a dietary supplement is misguided.

    The primary cannabinoids that define the chemistries of Epidiolex and Sativex are CBD and delta-9-tetrahydrocannabinol (THC), which are derived from the acidic precursors cannabidiolic acid (CBDA) and delta-9-tetrahydrocannabinolic acid (THCA).

    However, Cannabis sativa contains approximately 120 different cannabinoids, which have been described in peer-reviewed journal articles. Cannabinoids are unique to the Cannabis sativa plant and can be separated into two types, neutral cannabinoids and acidic cannabinoids, depending on whether they contain a carboxyl group.

    In live plants, cannabinoids are found in their acidic form. The decarboxylation reaction occurs through non-enzymatic processes, such as light exposure, heating, or aging. After the plant is harvested, each processing step—such as drying, milling, storage, extraction, and/or smoking—produces a little more of the neutral, decarboxylated cannabinoids.

    Fundamental Differences
    Simply stated, FSHE is fundamentally different from both Epidiolex and Sativex. Multicomponent hemp extract with trace levels of naturally occurring THC (< 0.3%) and other naturally occurring cannabinoids, terpenoids, flavonoids, and phytochemicals, has not been approved in any new drug. FSHE is further distinguished by:

    1. FSHE contains CBD and trace amounts of THC as a component of a more complex mixture that has not itself been approved as a drug.
    2. FSHE does not contain added CBD or THC.
    3. FSHE is being marketed for use at a dose level that would not expose consumers to the therapeutic levels of CBD or THC used in approved drugs.

    In the parlance of the Pharmanex opinion, the relationship between FSHE and Epidiolex and Sativex is a far cry from the nearly identical properties shared by Cholestin and prescription lovastatin products. FSHE exhibits differentiated pharmacological properties and is not the same “article” that is the subject of substantial clinical investigations or FDA approval for Dravet syndrome or Lennox-Gastaut syndrome—two rare forms of epilepsy. 

    To state it more concisely, FSHE and GW Pharma’s cannabis-derived drugs have nothing in common with each other. The NDIN exercise Irwin Naturals and Charlotte’s Web completed shows that FDA is unlikely to change its mind absent action by Congress to amend the law to make it clear that FSHE is not precluded under the FDCA.


    About the Author: Todd Harrison is partner with Venable, which is located in Washington, D.C. He advises food and drug companies on a variety of FDA and FTC matters, with an emphasis on dietary supplement, functional food, biotech, legislative, adulteration, labeling and advertising issues. He can be reached at 575 7th St. NW, Washington, D.C. 20004, Tel: 202-344-4724; E-mail: taharrison@venable.com. 
    Related Searches
    • Herbs & Botanicals
    • Regulations
    • Quality & Safety
    Related Knowledge Center
    • Quality & Safety
    • Regulations
    • Herbs & Botanicals
    Suggested For You
    Food Processing for Health and Wellness Food Processing for Health and Wellness
    Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality
    Lynside® Forte B offers full range of B-vitamin benefits with nutritional yeast Lynside® Forte B offers full range of B-vitamin benefits with nutritional yeast
    New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance
    FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products
    Autophagy (the Body’s Garbage Disposal) Key to Cellular Renewal Autophagy (the Body’s Garbage Disposal) Key to Cellular Renewal
    AIDP’s Puremune Receives Authorization for Health Claim in Canada AIDP’s Puremune Receives Authorization for Health Claim in Canada
    Informa to Hold Day-Long Summit on Mental Wellbeing Ahead of Vitafoods Europe 2022 Informa to Hold Day-Long Summit on Mental Wellbeing Ahead of Vitafoods Europe 2022
    Pharmactive Biotech Launches Aged Black Garlic Gummy Ingredient Pharmactive Biotech Launches Aged Black Garlic Gummy Ingredient
    Michelle Martin Combines Passion & Purpose as President and COO of Cypress Systems Michelle Martin Combines Passion & Purpose as President and COO of Cypress Systems
    NAC Supplements Could be Banned Unless FDA Reverses Course NAC Supplements Could be Banned Unless FDA Reverses Course
    Bergamot Polyphenolic Fractions May Lower Cholesterol Profile Bergamot Polyphenolic Fractions May Lower Cholesterol Profile
    Amino Acid Decision in Europe May Represent Small Step Toward Harmonization Amino Acid Decision in Europe May Represent Small Step Toward Harmonization
    High DHA, Low Linoleic Acid Medical Food Shown to Help Cognitive Recovery in Malnourished Children High DHA, Low Linoleic Acid Medical Food Shown to Help Cognitive Recovery in Malnourished Children
    Noochy Crisp Receives Best Tasting Functional Food Award at Vitafoods Europe Noochy Crisp Receives Best Tasting Functional Food Award at Vitafoods Europe

    Related Online Exclusives

    • Delivery & Dosage Technologies | Enzymes | Functional Foods & Beverages | Natural/Organic | Proteins, Peptides, Amino Acids | Research
      Food Processing for Health and Wellness

      Food Processing for Health and Wellness

      At IFT FIRST, a panel of researchers covered the benefits of upcycled materials and sustainable measures to produce health and wellness products.
      By Mike Montemarano, Associate Editor 08.09.22

    • Dietary Supplements | Herbs & Botanicals | Quality & Safety | Regulations | Testing
      Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality

      Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality

      Complex formulas, sophisticated adulteration, and cost expectations are key pressure points in the dietary supplement market.
      By Mike Montemarano, Associate Editor 07.18.22

    • Cardiovascular Health | Cognitive Function | Dietary Supplements | Eye Health | Immune Function | Sports Nutrition | Vitamins
      Lynside® Forte B offers full range of B-vitamin benefits with nutritional yeast

      Lynside® Forte B offers full range of B-vitamin benefits with nutritional yeast

      All-in-one formula ready to be used alone or combined with other nutrients for various health applications.


    • Consumer Trends | Diabetes & Blood Sugar Management | Functional Foods & Beverages | Healthcare Trends | Sweeteners
      New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance

      New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance

      Allulose, stevia, monk fruit, and more help brands reduce sugar while supplements offer consumers additional solutions.
      By Danielle Rose, Contributing Writer 06.02.22

    • Breaking News | Herbs & Botanicals | Industry & Market News | Quality & Safety | Regulations
      FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products

      FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products

      This marked the first time the agency took enforcement action against a delta-8 THC-containing product.
      05.04.22

    Loading, Please Wait..
    Trending
    • Study Examines Vitamin K2 Content In Cheese
    • Chenland Nutritionals Self-Affirms GRAS For Cumin UP60 Ingredient
    • Pycnogenol Evidenced To Have Skin Benefits In Dermatology Study
    • ADM And Benson Hill Partner To Scale High Protein Soy For U.S. Market
    Breaking News
    • Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    • ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    • Tazo Transitions to Regenerative Organic Agriculture
    • Protein Ingredient Formulated for Chronic Kidney Disease Patients
    • IADSA Calls for Addressing Discrepancies in Vitamin C Recommendations
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • A Growing Herbal Products Market Still Faces Formidable Threats, Challenges
    • Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality
    • Nutrition and Flavor: Formulating for Modern Product Preferences
    • Contract Manufacturing: Trials & Tribulations of Today’s Supply Chains
    • How Will the European Green Deal Impact Dietary Supplements?
    • What Do Consumers Know About the Gut Microbiome?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Tazo Transitions to Regenerative Organic Agriculture
    Coatings World

    Latest Breaking News From Coatings World

    What are you Reading this Week?
    SONGWON Industrial Group Reports Strong Q2 Financial Results
    PPG Completes COLORFUL COMMUNITIES Project for Boys & Girls Clubs of Greater Houston
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Aug. 13
    'Graft-on-a-Chip' Built to Improve Vascular Graft Success
    Abbott Invests €440 in New Irish Facility
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AskBio Appoints Clinical Ops Executives
    SpectrumX Partners With UK Contract Manufacturer
    GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Arkay Chairman Emeritus Howard Kaneff Has Died
    Nutricosmetics Market to Hit $13.7 Billion by 2030
    Estée Lauder Pledges 100% Electric Fleet of Vehicles by 2030
    Happi

    Latest Breaking News From Happi

    Self Care Trumps Home Care Post-Covid
    Sephora’s Virtual House of Beauty Returns with Exclusive Offerings
    JC Penney Appoints Chief Financial Officer
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Printing Ink Primer, Zeller+Gmelin Lead This Week’s News Stories
    Heidelberg Enjoys Successful Start to 2022-23 Fiscal Year
    Mimaki Announces New LATAM Website
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Esko, Constantia Flexibles announce acquisitions and more
    Hybrid Software joins The Flexo Xperience Center
    Flexo Wash LLC and Mike Potter celebrate 20 years
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Focke & Co. to Host Destination: Your Hygiene Hub on August 31
    Exports Dominate Chinese Trade of Tissues, Hygiene Products and Wipes
    Freudenberg to Present Friction Inserts for Wind Energy
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Aug. 13
    Dental 3D Printing Market is Expanding 20% Annually
    Study Results Released for Abbott's Concussion Blood Test
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: ALTANA, Universal Display and Emerson Top This Week’s Stories
    eMagin Corporation Announces 2Q 2022 Results
    Zebra Technologies’ Emission Reduction Targets Validated by SBTi

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login